Cargando…

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Primary progressive multiple sclerosis (PPMS) displays a highly variable disease progression with a characteristic accumulation of disability, what makes difficult its diagnosis and efficient treatment. The identification of microRNAs (miRNAs)-based signature for the early...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-San Martín, María, Gómez, Imma, Quiroga-Varela, Ana, Gonzalez-del Río, Marina, Robles Cedeño, René, Álvarez, Gary, Buxó, Maria, Miguela, Albert, Villar, Luisa M., Castillo-Villalba, Jessica, Casanova, Bonaventura, Quintana, Ester, Ramió-Torrentà, Lluís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743264/ https://www.ncbi.nlm.nih.gov/pubmed/36724195 http://dx.doi.org/10.1212/NXI.0000000000200069

Ejemplares similares

Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases
por: Muñoz-San Martín, María, et al.
Publicado: (2021)

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions
por: Muñoz-San Martín, María, et al.
Publicado: (2019)

Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors
por: Coll-Martinez, Clàudia, et al.
Publicado: (2023)

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
por: Coll‐Martinez, Clàudia, et al.
Publicado: (2021)

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
por: Bravo, Gary Álvarez, et al.
Publicado: (2022)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Disease-related knowledge measurement instruments of people affected by multiple sclerosis: protocol for a systematic psychometric review
por: Gonzalez-del-Rio, Marina, et al.
Publicado: (2021)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
por: Picón, Carmen, et al.
Publicado: (2021)

Clinical and radiological features of cerebral amyloid angiopathy-related inflammation
por: Bravo, Gary Álvarez, et al.
Publicado: (2021)

Clinical heterogeneity in patients with myoclonus associated to COVID-19
por: Álvarez Bravo, Gary, et al.
Publicado: (2022)

Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat(®) Methodology
por: Fernandez, Oscar, et al.
Publicado: (2021)

Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
por: Alvarez Bravo, G., et al.
Publicado: (2020)

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2
por: Álvarez Bravo, G., et al.
Publicado: (2020)

Paraneoplastic Limbic Encephalitis in a Male with Squamous Cell Carcinoma of the Lung
por: Sauri, Tamara, et al.
Publicado: (2015)

Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult
por: Tomas-Roig, J., et al.
Publicado: (2020)

CSF chitinase 3-like-1 association with disability of primary progressive MS
por: Pérez-Miralles, Francisco, et al.
Publicado: (2020)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders
por: Tomas‐Roig, Jordi, et al.
Publicado: (2018)

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
por: Pérez‐Miralles, Francisco Carlos, et al.
Publicado: (2021)

Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers
por: Fitzsimons, Stephen, et al.
Publicado: (2023)

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study
por: Robles-Sanchez, Miguel Angel, et al.
Publicado: (2023)

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
por: Gascón-Giménez, Francisco, et al.
Publicado: (2023)

Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation
por: González-Villà, Sandra, et al.
Publicado: (2017)

A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis
por: Trojano, Maria, et al.
Publicado: (2021)

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks
por: Valverde, Sergi, et al.
Publicado: (2018)

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
por: Aliaga-Gaspar, Pablo, et al.
Publicado: (2021)

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling
por: Valverde, Sergi, et al.
Publicado: (2015)

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
por: Vermersch, Patrick, et al.
Publicado: (2022)

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
por: Gil-Varea, Elia, et al.
Publicado: (2018)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
por: Villoslada, Pablo, et al.
Publicado: (2015)

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
por: Gil-Varea, Elia, et al.
Publicado: (2020)

In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
por: Cubas-Nuñez, Laura, et al.
Publicado: (2017)

El corazón de México : una aproximación a la identidad mexicana a través de la artesanía kitsch de San Miguel de Allende/
por: Cedeñǫ Villalba, Lizandra
Publicado: (2010)

Population variation in miRNAs and isomiRs and their impact on human immunity to infection
por: Rotival, Maxime, et al.
Publicado: (2020)

Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Huang, Junzhang, et al.
Publicado: (2022)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nq4siopmhm8k2hc1akbvmd7m08